286
Views
12
CrossRef citations to date
0
Altmetric
Research Article

Resveratrol solid lipid microparticles as dry powder formulation for nasal delivery, characterization and in vitro deposition study

, , , , , , & show all
Pages 735-742 | Received 10 May 2016, Accepted 07 Nov 2016, Published online: 28 Nov 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

M. N. Lavanya, R. Preethi, J. A. Moses & C. Anandharamakrishnan. (2022) Aerosol-based Pulmonary Delivery of Therapeutic Molecules from Food Sources: Delivery Mechanism, Research Trends, and the Way Forward. Food Reviews International 38:sup1, pages 753-788.
Read now
Zerong Li, Wenmei Qiao, Chenghao Wang, Heqiao Wang, Mengchao Ma, Xinyu Han & Jingling Tang. (2020) DPPC-coated lipid nanoparticles as an inhalable carrier for accumulation of resveratrol in the pulmonary vasculature, a new strategy for pulmonary arterial hypertension treatment. Drug Delivery 27:1, pages 736-744.
Read now

Articles from other publishers (10)

Rita Y. P. da Silva, Danielle L. B. de Menezes, Verônica da S. Oliveira, Attilio Converti & Ádley A. N. de Lima. (2023) Microparticles in the Development and Improvement of Pharmaceutical Formulations: An Analysis of In Vitro and In Vivo Studies. International Journal of Molecular Sciences 24:6, pages 5441.
Crossref
Vivek P. Chavda, Gargi Jogi, Nirav Shah, Mansi N. Athalye, Nirav Bamaniya, Lalitkumar K Vora & Ana Cláudia Paiva-Santos. (2022) Advanced particulate carrier-mediated technologies for nasal drug delivery. Journal of Drug Delivery Science and Technology 74, pages 103569.
Crossref
Aijun Di, Shengyu Zhang, Xuan Liu, Zhenbo Tong, Siping Sun, Zengchao Tang, Xiao Dong Chen & Winston Duo Wu. (2021) Microfluidic spray dried and spray freeze dried uniform microparticles potentially for intranasal drug delivery and controlled release. Powder Technology 379, pages 144-153.
Crossref
Chuanfen Pu, Wenting Tang, Mengyao Liu, Yinglian Zhu & Qingjie Sun. (2020) Resveratrol-loaded hollow kafirin nanoparticles via gallic acid crosslinking: An evaluation compared with their solid and non-crosslinked counterparts. Food Research International 135, pages 109308.
Crossref
Joana Bicker, Ana Fortuna, Gilberto Alves & Amílcar Falcão. (2020) Nose-to-brain Delivery of Natural Compounds for the Treatment of Central Nervous System Disorders. Current Pharmaceutical Design 26:5, pages 594-619.
Crossref
Laurent Salade, Nathalie Wauthoz, Jonathan Goole & Karim Amighi. (2019) How to characterize a nasal product. The state of the art of in vitro and ex vivo specific methods. International Journal of Pharmaceutics 561, pages 47-65.
Crossref
Valentina Trotta, Barbara Pavan, Luca Ferraro, Sarah Beggiato, Daniela Traini, Larissa Gomes Des Reis, Santo Scalia & Alessandro Dalpiaz. (2018) Brain targeting of resveratrol by nasal administration of chitosan-coated lipid microparticles. European Journal of Pharmaceutics and Biopharmaceutics 127, pages 250-259.
Crossref
Laura Tiozzo Fasiolo, Michele Dario Manniello, Elena Tratta, Francesca Buttini, Alessandra Rossi, Fabio Sonvico, Fabrizio Bortolotti, Paola Russo & Gaia Colombo. (2018) Opportunity and challenges of nasal powders: Drug formulation and delivery. European Journal of Pharmaceutical Sciences 113, pages 2-17.
Crossref
Awais Wahab, Kuo Gao, Caixia Jia, Feilong Zhang, Guihua Tian, Ghulam Murtaza & Jianxin Chen. (2017) Significance of Resveratrol in Clinical Management of Chronic Diseases. Molecules 22:8, pages 1329.
Crossref
Anne M. Dolberg & Stephan Reichl. (2017) Activity of Multidrug Resistance-Associated Proteins 1–5 (MRP1–5) in the RPMI 2650 Cell Line and Explants of Human Nasal Turbinate. Molecular Pharmaceutics 14:5, pages 1577-1590.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.